- Home
- MNRO vs AUTL Comparison
MNRO vs AUTL Comparison
Compare MNRO & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNRO
- AUTL
- Stock Information
- Founded
- MNRO 1957
- AUTL 2014
- Country
- MNRO United States
- AUTL United Kingdom
- Employees
- MNRO N/A
- AUTL N/A
- Industry
- MNRO Automotive Aftermarket
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNRO Consumer Discretionary
- AUTL Health Care
- Exchange
- MNRO Nasdaq
- AUTL Nasdaq
- Market Cap
- MNRO 530.9M
- AUTL 433.8M
- IPO Year
- MNRO 1991
- AUTL 2018
- Fundamental
- Price
- MNRO $18.13
- AUTL $1.54
- Analyst Decision
- MNRO Buy
- AUTL Strong Buy
- Analyst Count
- MNRO 3
- AUTL 5
- Target Price
- MNRO $18.33
- AUTL $9.12
- AVG Volume (30 Days)
- MNRO 609.8K
- AUTL 2.8M
- Earning Date
- MNRO 10-29-2025
- AUTL 11-11-2025
- Dividend Yield
- MNRO 6.15%
- AUTL N/A
- EPS Growth
- MNRO N/A
- AUTL N/A
- EPS
- MNRO N/A
- AUTL N/A
- Revenue
- MNRO $1,203,187,000.00
- AUTL $29,934,000.00
- Revenue This Year
- MNRO $2.15
- AUTL $641.63
- Revenue Next Year
- MNRO $3.03
- AUTL $109.21
- P/E Ratio
- MNRO N/A
- AUTL N/A
- Revenue Growth
- MNRO N/A
- AUTL 185.17
- 52 Week Low
- MNRO $12.20
- AUTL $1.11
- 52 Week High
- MNRO $30.18
- AUTL $4.69
- Technical
- Relative Strength Index (RSI)
- MNRO 56.63
- AUTL 46.56
- Support Level
- MNRO $17.88
- AUTL $1.58
- Resistance Level
- MNRO $18.55
- AUTL $1.72
- Average True Range (ATR)
- MNRO 0.60
- AUTL 0.11
- MACD
- MNRO 0.08
- AUTL -0.01
- Stochastic Oscillator
- MNRO 86.22
- AUTL 28.57
About MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.